BGM0504
A Study of BGM0504 in Participants With Obesity
BrightGene Bio-Medical Technology Co · Phase 2 · Completed · Enrollment 96
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| BGM0504 | n/r | n/r | n/r | n/r |
| Tirzepatide | n/r | n/r | n/r | n/r |
Not shown
- BGM0504: endpoint not reported
- Tirzepatide: endpoint not reported